Search

everythinglearnresearchcommunity

for

Search:↓

Not taking prescribed medications properly can lead to higher death rates from unrelated health conditions.

Finasteride reduces the need for prostate surgery but may increase the risk of depression and persistent sexual side effects.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

Case-only trees and random forests improve predictions of treatment effects in clinical trials.

Suppressing certain hormones might help prevent prostate cancer.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

The BJUI supports clinical trials as key for unbiased medical evidence and works to enhance their design, reporting, and discussion.

PrEP for HIV is less effective in transgender women mainly due to low adherence to the treatment.

5α-reductase inhibitors, like finasteride and dutasteride, effectively treat BPH, male baldness, and hirsutism, with potential for acne and prostate cancer prevention.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

Finasteride, a hair loss drug, may cause sexual dysfunction and depression, but these effects are usually temporary and the drug is generally safe. More research is needed.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Finasteride for hair loss is safe and does not increase the risk of high-grade prostate cancer.

The document concludes that accurately identifying leukemia types is crucial, and the risks of cancer from finasteride need careful evaluation against its benefits.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Selenium and vitamin E supplements have mixed effects on prostate cancer risk and may not be beneficial for everyone.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.

There is no clear recommendation for using selenium in cancer patients; it may be beneficial to correct low selenium levels before treatment.

The current system can't fully test all combination treatments, so alternative methods and regulatory flexibility are needed.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Certain drugs that block specific enzymes can help treat prostate diseases.

Short-term finasteride treatment may lower some cell death factors in prostate cancer cells.

The document concludes that better research methods are needed in men's sexual health to provide stronger evidence and improve patient care.

Five-alpha reductase inhibitors, like finasteride and dutasteride, can treat enlarged prostates, improve urination, reduce need for prostate surgery, and lower the risk of prostate cancer, but may increase the risk of higher grade prostate cancer. They can also treat male pattern baldness.

The conclusion is that individualized treatment and proper medication use are crucial in men's health, with specific recommendations for ED, BPH, and prostate cancer management.

Finasteride for hair loss may increase the risk of certain cancers and has side effects; better regulation and education on its use are needed.